Stempeutics Research Profile
Key Indicators
- Authorised Capital ₹ 65.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 59.67 Cr
as on 24-10-2024
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.18 Cr
as on 24-10-2024
- Revenue 357.64%
(FY 2023)
- Profit 49.71%
(FY 2023)
- Ebitda -41.07%
(FY 2023)
- Net Worth 52.97%
(FY 2023)
- Total Assets 5.03%
(FY 2023)
About Stempeutics Research
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 65.00 Cr and a paid-up capital of Rs 59.67 Cr.
The company currently has active open charges totaling ₹2.18 Cr.
The Key Managerial Personnel (KMP) at Stempeutics Research Private Limited India is Kriti Agarwal as COMPANY SECRETARY. Anurag Bagaria, Manohar Narasimhan, Hebri Ballal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U73100KA2006PTC038256
- Company No.
038256
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jan 2006
- Date of AGM
19 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Stempeutics Research Private Limited offer?
Stempeutics Research Private Limited offers a wide range of products and services, including Natural Therapy Services, Stem Cell Therapy, Dermatology Treatment Services, Medical Surgery & Treatment Centres, Medical Facilities, Medical Equipment & Accessories, Life Support Machines, Hospital Equipment.
Who are the key members and board of directors at Stempeutics Research?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manohar Narasimhan  | Managing Director | 26-Aug-2009 | Current |
| Kriti Agarwal | Company Secretary | 21-Mar-2023 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Umang Vohra | Director | 03-Jan-2024 | Current |
| Anurag Bagaria | Director | 27-Jun-2019 | Current |
| Hebri Ballal | Director | 19-Jan-2012 | Current |
| Jaideep Gogtay | Nominee Director | 05-Jun-2011 | Current |
Financial Performance and Corporate Structure Insights of Stempeutics Research.
Stempeutics Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 357.64% increase. The company also saw a substantial improvement in profitability, with a 49.71% increase in profit. The company's net worth Soared by an impressive increase of 52.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stempeutics Research?
In 2023, Stempeutics Research had a promoter holding of 46.49% and a public holding of 53.51%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Manipal Hospitals (Bengaluru) Private LimitedActive 15 years 9 months
Hebri Ballal is a mutual person
Manipal Hospitals (East) India Private LimitedActive 38 years 8 monthsHebri Ballal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 19 Nov 2021 | ₹2.84 M | Open |
Biotechnology Industry Research Assistance Council Creation Date: 31 Dec 2011 | ₹1.89 Cr | Open |
How Many Employees Work at Stempeutics Research?
Stempeutics Research has a workforce of 27 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stempeutics Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stempeutics Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
